Summary by Futu AI
DEKI PHARMACEUTICALS LIMITED FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 3 MAY 2024, COVERING THE SITUATION AS OF 30 APRIL 2024. The report shows that the company's regulated/registered share capital remained unchanged, with 2,000,000,000 shares outstanding at the end of last month and deposits at the end of this month, with a face value of $0.0001 per share, totaling $200,000. In addition, 223,580 shares and 343,600 share options were written off in the Company's Stock Option Plan 2019 and Stock Incentive Plan 2020, respectively. After the write-off, the stock options under the 2019 Plan and the 2020 Plan were outstanding for 14,104,046 shares and 15,425,620 shares, respectively. No funds received during the month due to exercise options. The report does not mention other agreements or arrangements for issuing shares and information relating to Hong Kong pre-trust securities.